Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026)
Sagimet Biosciences' Non-Current Assets was $19.44 million in Q2 2026, up 90.4% from $10.21 million a year earlier.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Sagimet Biosciences came in at $78,000, down 99.0% from FY2024.
- Non-Current Assets shows a three-year compound annual growth rate of -31.2% (FY2022 to FY2025).
- In earlier years, Non-Current Assets was $7.49 million in FY2024, $73,000 in FY2023 (-69.5%) and $239,000 in FY2022.
- The Q2 2026 figure marks the highest quarterly Non-Current Assets since Q2 2024.
- Compared with a year earlier, Non-Current Assets was higher in two of the last six quarters, with an average decline of 0.5%.
- Per Business Quant data, SGMT's Non-Current Assets in the three quarters before Q2 2026 was $39,000 (Q1 2026), $78,000 (Q4 2025) and $8.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Sagimet Biosciences | 527.96 Mn | 527.96 Mn | - | 19.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.44 Mn |
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 10.21 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 7.49 Mn |
| Sep 30, 2024 | 17.59 Mn |
| Jun 30, 2024 | 22.27 Mn |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Dec 31, 2022 | 239,000.00 |
API Access
Sagimet Biosciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();